These results indicate that FRRG-MMAE nanoparticles inhibit tubulin polymerization by releasing MMAE molecules owing to the overexpressed cathepsin B in the tumor cells, but they maintain inactive states in the cathepsin B-deficient normal cells. The gene discussed is CTSB; the disease is neoplasm.